Fact CheckerSign in

NCT06588231Recruiting

Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease

Effect of Individualized Exercise Based on CPET on Multiple Cardiovascular Risk Factors and Cardiopulmonary Function in Elderly Patients With Coronary Heart Disease

Source: ClinicalTrials.gov · Last updated 31 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The benefits of cardiac rehabilitation have been supported by a large amount of evidence-based medicine. Cardiac rehabilitation can correct cardiovascular risk factors, reduce morbidity and mortality, and improve quality of life.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
200 (estimated)
First submitted
28 Aug 2024
Start date
17 Oct 2023
Primary completion date
17 Dec 2024
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
NCT number
NCT06588231

What you commit to

  • Study type: Interventional
  • Planned participants: 200
  • From 17 Oct 2023 to the primary completion date, 17 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Antibiotics and anti-diarrheal medications have not been used for at least 3 months.

Other illness

  • Patients with severe organic cardiac and lung diseases.
  • Patients with hemiplegia and other physical action disorders.
  • A history of mental illness.
  • Uncontrolled hypertension, and hemodynamic instability.
  • Severe nephropathy and severe peripheral artery disease.
  • Patients with bone and joint diseases who are not suitable for exercise.
  • Uncontrolled endocrine system and other diseases.

Who the study is looking for

  • Coronary heart disease: coronary angiography confirmed patients with coronary heart disease.
  • Age is 60-75 years old, and the clinical sinus rhythm is stable.
  • Left ventricular ejection fraction was\> 40%.
  • Informed consent and voluntary participation.

Age in the registry: 60 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The First Affiliated Hospital of Nanjing Medical University
Coordinator of this site? Confirm its status
NanjingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.